0001655774-21-000002.txt : 20210331 0001655774-21-000002.hdr.sgml : 20210331 20210330175211 ACCESSION NUMBER: 0001655774-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210331 DATE AS OF CHANGE: 20210330 EFFECTIVENESS DATE: 20210331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoResponse Inc CENTRAL INDEX KEY: 0001655774 IRS NUMBER: 475120470 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-394093 FILM NUMBER: 21788699 BUSINESS ADDRESS: STREET 1: 1124 COLUMBIA STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: (206) 805-1600 MAIL ADDRESS: STREET 1: 1124 COLUMBIA STREET STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001655774 OncoResponse Inc 1124 COLUMBIA STREET SUITE 300 SEATTLE WA WASHINGTON 98104 (206) 805-1600 DELAWARE None None Corporation true Clifford Stocks 1124 Columbia Street Suite 300 Seattle WA WASHINGTON 98104 Executive Officer Director Roberto DePonti 412F Route D'Esch L-2086 None N4 LUXEMBOURG L-2086 Director Steven Gillis 8725 West Higgins Road Suite 290 Chicago IL ILLINOIS 60631 Director Wende Hutton 2765 Sand Hill Road Menlo Park CA CALIFORNIA 94025 Director Ted Koutouzis 1603 Orrington Avenue 13th Floor Evanston IL ILLINOIS 60201 Director John McKearn 101 S. Hanley Road Suite 1850 St. Louis MO MISSOURI 63105 Director Patrick Joseph Hojlo Qatar Investment Authority P.O. Box 23224 Doha S3 QATAR Zone 61 Director Daguang Wang 1 Broadway 14th Floor Cambridge MA MASSACHUSETTS 02142 Director Bob Lechleider 1124 Columbia Street Suite 300 Seattle WA WASHINGTON 98104 Executive Officer Kamal Puri 1124 Columbia Street Suite 300 Seattle WA WASHINGTON 98104 Executive Officer Biotechnology Decline to Disclose 06b false 2021-03-17 false true false 0 60000000 40625995 19374005 false 14 0 0 1400000 true The amount reflects payment of accrued and unpaid bonuses from periods prior to the offering and anticipated salary to the listed executive officers and potential bonus payments for the following 24-month period. false OncoResponse Inc Clifford J. Stocks Clifford J. Stocks Chief Executive Officer 2021-03-30